Pooled Analysis of Rivaroxaban therapy for acute venous thromboembolism in FIRST registry, SWIVTER and DRESDEN NOAC registry

Stephanie Müller,Luise Tittl,Victoria Speed,Lara Roberts,Jignesh Patel,Raj Patel,Roopen Arya,Nils Kucher,David Spirk,Kurtulus Sahin,Jan Beyer‐Westendorf

Research and Practice in Thrombosis and Haemostasis（2022）

引用 0|浏览13

暂无评分

摘要

Overall treatment outcomes were consistent with the results of the phase III rivaroxaban trials in VTE treatment, indicating that the use of rivaroxaban offers acceptable treatment results also in routine care. However, we observed significant differences in patient characteristics and management patterns across Switzerland, the United Kingdom, and Germany, limiting direct comparisons of unadjusted outcome event rates between registries.

查看译文

关键词

anticoagulant,hemorrhage,registries,rivaroxaban,venous thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要